» Articles » PMID: 17606663

Identification of Functional Polymorphisms in the Promoter Region of the Human PICK1 Gene and Their Association with Methamphetamine Psychosis

Abstract

Objective: Protein interacting with C-kinase-1 (PICK1) plays a role in the targeting and clustering of dopamine transporter, which is the primary target site for the abused drug methamphetamine. Based on the interaction of PICK1 with dopamine transporter, it is of particular interest to investigate the association between the PICK1 gene and methamphetamine abusers.

Method: The authors studied the association between PICK1 gene polymorphisms and methamphetamine abusers in a Japanese group. Two hundred and eight methamphetamine abusers and 218 healthy comparison subjects were enrolled in the study. Furthermore, the authors also examined the effects of single nucleotide polymorphisms (SNPs) in the promoter and 5'-untranslated region on transcription levels of PICK1.

Results: The authors identified four highly frequent SNPs, rs737622 (-332 C/G) and rs3026682 (-205 G/A) in the promoter region and rs713729 (T/A) in intron3 and rs2076369 (T/G) in intron4. Of these SNPs, rs713729 was significantly associated with methamphetamine abusers in general, and rs713729 and rs2076369 were significantly associated with those with spontaneous relapse of psychosis. Furthermore, haplotype analysis revealed that specific haplotypes of these SNPs were associated with methamphetamine abusers. A gene reporter assay revealed that the two SNPs in the promoter region significantly altered transcriptional activity.

Conclusions: Our findings suggest that the PICK1 gene may be implicated in the susceptibility to spontaneous relapse of methamphetamine psychosis and that, as an intracellular adapter protein, PICK1 may play a role in the pathophysiology of methamphetamine psychosis.

Citing Articles

Assessment of resting cerebral perfusion between methamphetamine-associated psychosis and schizophrenia through arterial spin labeling MRI.

Hwang Z, Li C, Hsu A, Wu C, Chan W, Huang M Eur Arch Psychiatry Clin Neurosci. 2024; .

PMID: 38970667 DOI: 10.1007/s00406-024-01857-1.


Association of PICK1 and BDNF variations with increased risk of methamphetamine dependence among Iranian population: a case-control study.

Tajbakhsh A, Alimardani M, Asghari M, Abedini S, Saghafi Khadem S, Bajestani A BMC Med Genomics. 2021; 14(1):27.

PMID: 33499851 PMC: 7836203. DOI: 10.1186/s12920-021-00873-7.


Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.

Guerin A, Nestler E, Berk M, Lawrence A, Rossell S, Kim J Neurosci Biobehav Rev. 2020; 120:48-74.

PMID: 33217458 PMC: 7856253. DOI: 10.1016/j.neubiorev.2020.11.001.


Genetic Analysis of Gene in Alzheimer's Disease: A Study for Finding a New Gene Target.

Xu L, Chen Y, Shen T, Lin C, Zhang B Front Neurol. 2019; 9:1169.

PMID: 30687223 PMC: 6333664. DOI: 10.3389/fneur.2018.01169.


Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities.

Okazaki K, Makinodan M, Yamamuro K, Takata T, Kishimoto T Neuropsychiatr Dis Treat. 2016; 12:3195-3198.

PMID: 28008256 PMC: 5167479. DOI: 10.2147/NDT.S120374.